Atopic Dermatitis Drugs Market, Emerging Trends and Challenges & Forecasts To 2025 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Atopic Dermatitis Drugs Market, Emerging Trends and Challenges & Forecasts To 2025

Description:

Global Market Estimates is a market research and business consulting company who has proven track record in serving Fortune 500 companies. Request for a sample copy of the ‘Atopic Dermatitis Drugs Market’ report @: – PowerPoint PPT presentation

Number of Views:9

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Atopic Dermatitis Drugs Market, Emerging Trends and Challenges & Forecasts To 2025


1
GLOBAL MARKET ESTIMATES RESEARCH
CONSULTANTS Ankita Roy, Treesha Banerjee and
Liza Dsouza from Global Market Estimates throw
the spotlight on the growing Atopic Dermatitis
Drugs Market Atopic Dermatitis Drugs Market
Insights The Global Atopic Dermatitis Drugs
market is expected to grow at a significant CAGR
during the forecast period. Factors such as
rising prevalence of atopic dermatitis in infants
and awareness about the availability of
treatments for the disease are expected to drive
growth in the atopic dermatitis drugs market
during the forecast period. Further, initiatives
taken by the Government to provide affordable
treatment for atopic dermatitis in emerging
economies is expected to positively affect the
demand for atopic dermatitis drugs However,
factors such as high cost of biologics drugs for
atopic dermatitis is expected to have a negative
impact on the market up to a certain
extent. Atopic Dermatitis Drugs Market Drug
Class Insights On the basis of drug class, the
Atopic Dermatitis Drugs market can be classified
into Corticosteroids, Calcineurin Inhibitors,
PDE4 Inhibitors, and Biologics among others.
Corticosteroids are expected to hold the largest
market share in terms of revenue during the
forecast period, being the first-line therapy.
PDE4 Inhibitors and Biologics segments are
expected to grow at a significant CAGR owing to
growing adoption of targeted therapy. The
Biologics segment is however expected to hold a
smaller market share, as it is a drug prescribed
when the patient does not respond to any
first-line treatment drugs. Atopic Dermatitis
Drugs Market Mode of Administration
Insights The Global Atopic Dermatitis Drugs
market is segmented into Topical, Oral, and
Injectable based on the mode of administration.
The topical drugs segment is projected to hold
the largest market share in terms of revenue.
The injectable drugs segment is expected to grow
at the highest CAGR during the forecast period
owing to the development of new technology and
new product launches. Atopic Dermatitis Drugs
Market Regional Insights North America is
expected to hold the largest market share in
terms of revenue, which is dominated by the U.S.
Rising incidence of atopic dermatitis and
awareness about advanced drugs are expected to
boost the demand for atopic dermatitis drugs in
the region. The Asia Pacific region is expected
to grow at the highest CAGR owing to high
population and rising awareness about healthcare
in the region. Japan is projected to contribute
significantly to growth in the Asia Pacific
market for atopic dermatitis.
2
  • GLOBAL MARKET ESTIMATES RESEARCH CONSULTANTS
  • Atopic Dermatitis Drugs Market End-Use Landscape
  • The end-use landscape entails a list of current
    and prospective consumers prevailing across the
    regions. This section provides company addresses,
    contact details, products, and regional presence
    of companies who are purchasing or are likely to
    purchase controlled release fertilizer over the
    coming years. Some leading consumers of
    controlled release fertilizer are LifePoint
    Health, CVS Corporation, and Cipla among others.
  • Atopic Dermatitis Drugs Market Vendor Landscape
  • The report contains a chapter dedicated to
    vendors operating in the market, covering raw
    material manufactures, equipment developers,
    manufacturers, and distributors. The report
    provides these insights on a regional level. This
    section of the report entails contact details,
    experience, products manufactured/supplied, and
    geographical presence of companies.
  • Atopic Dermatitis Drugs Market Share
    Competitor Analysis
  • Some of the key players operating in the Atopic
    Dermatitis Drugs market are Bayer, LEO Pharma,
    Mylan, Pfizer, and Sanofi among others.
  • Sanofi is expected to launch a new Antibody Drug
    Dupilumab for Atopic Dermatitis in late 2018.
  • In March 2017, the U.S. Food Drug
    Administration approved the drug Dupizent, which
    is an injectable drug used to treat atopic
    dermatitis in adults.

3
  • GLOBAL MARKET ESTIMATES RESEARCH CONSULTANTS
  • By Mode of Administration
  • Topical
  • Oral
  • Injectable
  • By Region
  • North America
  • Europe
  • Asia Pacific
  • Central South America
  • Middle East Africa
  • This article contains text from the Atopic
    Dermatitis Drugs Market Forecast to 2025
    report prepared by Global Market Estimates. For
    more information or to buy the report, please
    visit https//www.globalmarketestimates.com/atopi
    c-dermatitis-drugs-market/
  • Check our annual research partnership service at
About PowerShow.com